Home > Insider Trading > Filing (0001144204-12-039619)

Filing Details

Accession Number:: 0001144204-12-039619
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-07-16 16:18:40
Reporting Period:: 2012-07-12

Filing Date:: 2012-07-16
Accepted Time:: 2012-07-16 16:18:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887497	Hi Tech Pharmacal Co Inc	HITK	Pharmaceutical Preparations (2834)	112638720

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1303569	W Bruce Simpson	C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY US 11701		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-07-12	3,094	$14.99	3,094	No	4	M	Direct
Common Stock	Acquisiton	2012-07-12	6,187	$9.65	9,281	No	4	M	Direct
Common Stock	Acquisiton	2012-07-12	6,188	$5.83	15,469	No	4	M	Direct
Common Stock	Acquisiton	2012-07-12	3,093	$19.59	18,562	No	4	M	Direct
Common Stock	Disposition	2012-07-12	18,562	$27.75	0	No	4	S	Direct
Common Stock	Acquisiton	2012-07-13	1,907	$19.59	1,907	No	4	M	Direct
Common Stock	Disposition	2012-07-13	1,907	$29.33	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-07-12	3,094	$0.00	3,094	$14.99
Commonstock	Stock Option (Right to Buy)	Disposition	2012-07-12	6,187	$0.00	6,187	$9.65
Common Stock	Stock Option (Right to Buy)	Disposition	2012-07-12	6,188	$0.00	6,188	$5.83
Common Stock	Stock Option (Right to Buy)	Disposition	2012-07-12	3,093	$0.00	3,093	$19.59
Common Stock	Stock Option (Right to Buy)	Disposition	2012-07-13	1,907	$0.00	1,907	$19.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2007-11-09	2016-11-09	No	4	M	Direct
0	2008-11-15	2017-11-15	No	4	M	Direct
3,093	2009-11-13	2018-11-13	No	4	M	Direct
6,907	2010-11-12	2019-11-12	No	4	M	Direct
5,000	2010-11-12	2019-11-12	No	4	M	Direct

Footnotes

The price reported in this column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.35 to $28.05, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., shares, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in this column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.24 to $29.48, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., shares, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
The option became (or becomes) exercisable in four equal annual installments beginning on the first anniversary of the grant date.
Other than the options to acquire an aggregate of 8,093 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 22,375 shares of Hi-Tech Pharmacal Co., Inc. common stock (for total options to acquire an aggregate of 30,468 shares currently held by the filer) which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.